Pfizer (PFE) Completes Acquisition of Wyeth (WYE)
More News related to PFE
- Active equity option families in first 30 minutes: PFE, BAC, CSCO, AMZN, AAPL
- Pfizer and Keas Partner to Help Consumers Take a More Active Role in Their Health and Wellness
- Top 10 News Items 2/1-2/5: 9.7% Unemployment Rate Surprises the Market, Dow Breaks 10,000, But Recovers, Troubles at Toyota Continue
- Active equity option families in first 30 minutes: BAC F PFE AAPL
- QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients
More News related to WYE
- Pfizer (PFE) Completes Acquisition of Wyeth (WYE)
- U.S. antitrust regulators cleared the Pfizer (PFE), Wyeth (WYE) merger
- Progenics Pharma (PGNX) Regains RELISTOR Rights from Wyeth (WYE)
- S&P Announces Changes to US Indices: NWSA for WYE, FSLR for WYE
- Notable Mergers and Acquisitions of the Day 9/29: SNR, PFE/WYE, CIR
More News related to Mergers and Acquisitions
- Airgas (ARG) Rejects Air Products (APD) Takeover Bid
- Sony (SNE) Subsidiary Acquires iCyt Mission Tech
- Audiovox Corp. (VOXX) Acquires Assets of Invision Industries
- Morningstar (MORN) Buys Footnoted.org
- Volcano Corp. (VOLC) Acquires Xtract Catheter Device from Lumen Biomed
Pfizer (NYSE: PFE) and Wyeth (NYSE: WYE) announced today that Pfizer has completed its acquisition of Wyeth following the receipt of regulatory approval from all government authorities required by the merger agreement and approval by Wyeth shareholders.
Under the terms of the transaction, each outstanding share of Wyeth common stock has been converted into the right to receive $33 in cash (without interest) and 0.985 of a share of Pfizer common stock.
Related Categories
Mergers and AcquisitionsStocks Mentioned
+0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
